ARCHIVES

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

Final Money Bill Clear On Permitting New Construction Funding

December 12, 1975

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

June 28, 2013

Cancer Nurses Urged To Take ‘Proactive Stance’ against Budget Cutting

October 16, 1987

NCI Launches ALCHEMIST

September 5, 2014

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988